Showing results (151-160 of 168) with videos related to

Sort By:
Pageof 17
AIDS (London, England)|July 14, 2000
Phenotypic and genotypic analysis of clinical HIV-1 isolates reveals extensive protease inhibitor cross-resistance: a survey of over 6000 samplesK Hertogs, S Bloor, S D Kemp, et al.
The Journal of Infectious Diseases|May 1, 1995
Combination therapy with zidovudine prevents selection of human immunodeficiency virus type 1 variants expressing high-level resistance to L-697,661, a nonnucleoside reverse transcriptase inhibitorS Staszewski, F E Massari, A Kober, et al.
JAMA|July 10, 1996
Safety and efficacy of lamivudine-zidovudine combination therapy in zidovudine-experienced patients. A randomized controlled comparison with zidovudine monotherapy. Lamivudine European HIV Working GroupS Staszewski, C Loveday, J J Picazo, et al.
The Journal of Infectious Diseases|June 2, 1998
Dual resistance to zidovudine and lamivudine in patients treated with zidovudine-lamivudine combination therapy: association with therapy failureV Miller, A Phillips, C Rottmann, et al.
AIDS (London, England)|January 12, 2001
Virological and immunological effects of treatment interruptions in HIV-1 infected patients with treatment failureV Miller, C Sabin, K Hertogs, et al.
AIDS (London, England)|June 10, 1998
The M184V mutation in HIV-1 reverse transcriptase (RT) conferring lamivudine resistance does not result in broad cross-resistance to nucleoside analogue RT inhibitorsV Miller, M Stürmer, S Staszewski, et al.
European Journal of Medical Research|April 17, 1999
Pneumocystis carinii pneumonia in the Federal Republic of Germany in the era of changing antiretroviral therapy - IDKF 13 -. German AIDS Study Group (GASG/IdKF)A Stoehr, K Arasteh, S Staszewski, et al.
Antimicrobial Agents and Chemotherapy|August 3, 1999
A family of insertion mutations between codons 67 and 70 of human immunodeficiency virus type 1 reverse transcriptase confer multinucleoside analog resistanceB A Larder, S Bloor, S D Kemp, et al.
The New England Journal of Medicine|December 22, 1999
Efavirenz plus zidovudine and lamivudine, efavirenz plus indinavir, and indinavir plus zidovudine and lamivudine in the treatment of HIV-1 infection in adults. Study 006 TeamS Staszewski, J Morales-Ramirez, K T Tashima, et al.
European Journal of Medical Research|May 18, 2007
Consensus recommendation from a group of German experts for the use of enfuvirtide in heavily pretreated HIV patientsB Salzberger, M Däumer, P Gute, et al.
Pageof 17